Open AccessDREADD Agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo
Author(s) -
S.T Slocum,
J.F. Diberto,
T.L. Kash,
A.B. Tobin,
B.L. Roth,
Jiaxin Liu,
S.J. Bradley,
J.S. Navarrete,
J. Jin,
D. Pati,
C. Molloy,
E. Khajehali,
K.M. Boyt,
K.J. Thompson,
A. Christopoulos,
M.M. Pina,
R.H.J. Olsen,
Yiting Xiong,
M.J. Krashes,
X.P. Huang,
C. Bundgaard,
P.M. Sexton
Publication year - 2020
Publication title -
figshare
Language(s) - English
DOI - 10.17615/g3y2-9z91
Subject(s) - agonist , in vivo , muscarinic agonist , muscarinic acetylcholine receptor , pharmacology , neuroscience , in vitro , chemistry , medicine , receptor , psychology , biology , biochemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom